Inhibrx Biosciences (INBX) Q3 2023 Earnings

9NovConfirmed
Q4 2022
Q1 2023
Q2 2023
Q3 2023
-1.12
-1.01
-0.9
-0.79

Details

Expected EPS
-1.01
Actual EPS
-1.1
Surprise EPS
-0.09
Surprise Percent
+8.91%

Description

Inhibrx Biosciences (INBX) has reported earnings of -1.1 per share for Q3 2023.

0 Comments

Share your thoughts